Aura Biosciences, Inc. (NASDAQ:AURA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Jeremy Bender Other companies: Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); Mereo BioPharma Group plc (Non-Executive Director · Since at least Jan 1, 2024); Day One Biopharmaceuticals Inc (CHIEF EXECUTIVE OFFICER, Director · Since at least May 26, 2021); Fusion Pharmaceuticals Inc (Director · Oct 16, 2023 – Jun 4, 2024 · Past) | Director · Since at least Jul 7, 2026 |
| Sapna Srivastava Other companies: Alumis Inc. (Director · Since at least Jul 30, 2025); Nuvalent, Inc. (Director · Since at least Jun 18, 2025); Tourmaline Bio Inc. (Director · Since at least Jun 4, 2025) | Director · Since at least Jun 17, 2025 |
| David Johnson Other companies: Zentalis Pharmaceuticals, Inc. (Director · Since at least Jun 16, 2026); Dynavax Technologies Corporation (Vice President · Jun 2, 2019 – Mar 13, 2020 · Past) | Director · Since at least May 4, 2026 |
| Anthony S Gibney Other companies: InflaRx N.V. (Director · Since at least Mar 18, 2026) | See Remarks · Since at least May 13, 2025 |
| Antony Mattessich Other companies: Ocular Therapeutix, Inc. (President and CEO, Director · Jun 20, 2017 – Feb 3, 2024 · Past) | Director · Since at least Oct 28, 2021 |
| Rajesh R Parekh Other companies: Celldex Therapeutics, Inc. (Director · Dec 23, 2009 – Sep 22, 2010 · Past) | Director · Oct 28, 2021 – Jun 7, 2023 · Past |
| Amy Elazzouzi | Principal Accounting Officer, Senior Vice President of Finance and Treasurer · Since at least Oct 25, 2024 |
| Anthony Daniels | Vice President, Therapeutic Area Head Ocular Oncology · Since at least Nov 5, 2026 |
| Conor Kilroy | See Remarks · Since at least Apr 16, 2026 |
| Erica Kratz | Chief Regulatory and Quality Officer · Since at least Aug 11, 2026 |
| Giovanni Mariggi | Director · Since at least Oct 28, 2021 |
| Janet Jill Hopkins | Chief Medical Officer · Since at least Sep 1, 2026 |
| Jill Hopkins | Chief Medical Officer, President of Research & Development · Since at least Jun 1, 2026 |
| Julie Person | Chief People Officer · Since at least Aug 11, 2026 |
| Natalie Holles | Chief Executive Officer and President and member of the Board · Since at least May 19, 2026 |
| Patrick Nealon | Senior Vice President, Clinical Development Operations · Since at least Nov 5, 2026 |
| Pinos Elisabet de los | See Remarks, Director · Since at least Oct 28, 2021 |
| Susan Abu-Absi | Chief Operating Officer · Since at least Aug 10, 2026 |
| Teresa Bitetti | Director · Since at least Apr 2, 2025 |